2024 Q4 Form 10-Q Financial Statement
#000190359624000660 Filed on November 14, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
Revenue | $207.00 | ||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | $172.0K | $34.50K | |
YoY Change | 398.72% | -84.36% | |
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $172.0K | $34.50K | |
YoY Change | 398.72% | -84.36% | |
Operating Profit | -$491.6K | $195.6K | |
YoY Change | -351.35% | -2.47% | |
Interest Expense | $16.82K | $4.003K | |
YoY Change | 320.06% | 52.21% | |
% of Operating Profit | 2.05% | ||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$885.9K | -$447.5K | |
YoY Change | 97.99% | ||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$885.9K | -$447.5K | |
YoY Change | 97.99% | 47.21% | |
Net Earnings / Revenue | -427991.3% | ||
Basic Earnings Per Share | -$0.01 | $0.00 | |
Diluted Earnings Per Share | -$0.01 | $0.00 | |
COMMON SHARES | |||
Basic Shares Outstanding | 159.9M shares | 159.0M shares | 315.2M shares |
Diluted Shares Outstanding | 159.4M shares | 315.2M shares |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $43.35K | $6.632K | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | $33.52K | $4.133K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $136.9K | $10.77K | |
YoY Change | 1171.43% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $136.9K | $10.77K | |
Total Long-Term Assets | $0.00 | $0.00 | |
Total Assets | $136.9K | $10.77K | |
YoY Change | 1171.43% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.466M | $1.356M | |
YoY Change | 81.86% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.466M | $1.356M | |
Total Long-Term Liabilities | |||
Total Liabilities | $2.466M | ||
YoY Change | |||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$7.103M | -$3.793M | |
YoY Change | 87.3% | ||
Common Stock | $159.9K | $323.6K | |
YoY Change | -50.58% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$2.329M | -$1.345M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $136.9K | $10.77K | |
YoY Change | 1171.43% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$885.9K | -$447.5K | |
YoY Change | 97.99% | 47.21% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | |||
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | |||
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | |||
Cash From Investing Activities | |||
Cash From Financing Activities | |||
Net Change In Cash | |||
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | |||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
333-271439 | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
159912808 | shares |
CY2023Q4 | us-gaap |
Cash
Cash
|
108335 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
4133 | usd |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Ludwig Enterprises, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
61-1133438 | ||
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
159364580 | shares |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
159364580 | shares |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001960262 | ||
CY2023Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
usd | |
CY2023Q4 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
usd | |
CY2023Q4 | LUDG |
Common Stock Issuable
CommonStockIssuable
|
usd | |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
usd | |
us-gaap |
Revenues
Revenues
|
usd | ||
CY2024Q3 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
usd | |
CY2023Q3 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
usd | |
us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
usd | ||
CY2024Q3 | LUDG |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
usd | |
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
CY2024Q2 | LUDG |
Stock Issued During Period Value Issued Common Stock Issuable For Services
StockIssuedDuringPeriodValueIssuedCommonStockIssuableForServices
|
usd | |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | |
us-gaap |
Noncash Merger Related Costs
NoncashMergerRelatedCosts
|
usd | ||
us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
usd | ||
LUDG |
Stock Warrants Issued For Finance Expense
StockWarrantsIssuedForFinanceExpense
|
usd | ||
LUDG |
Other Noncash Income Expenses
OtherNoncashIncomeExpenses
|
usd | ||
LUDG |
Provision For Obsolete Inventory
ProvisionForObsoleteInventory
|
usd | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
usd | ||
us-gaap |
Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
|
usd | ||
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
usd | ||
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
usd | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | ||
us-gaap |
Notes Issued1
NotesIssued1
|
usd | ||
us-gaap |
Stock Issued1
StockIssued1
|
usd | ||
CY2023Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
usd | |
CY2023 | LUDG |
Stock Issued During Period Value Conversion Of Convertible Securities2
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities2
|
usd | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
usd | |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
8950 SW 74th Ct | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Ste 2201-A149 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Miami | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33156 | ||
dei |
City Area Code
CityAreaCode
|
786 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
363-0166 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
No | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
CY2024Q3 | us-gaap |
Cash
Cash
|
43352 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
33517 | usd |
CY2024Q3 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
60000 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
136869 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
112468 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
136869 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
112468 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
561934 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
204024 | usd |
CY2024Q3 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
1270009 | usd |
CY2023Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
1270009 | usd |
CY2024Q3 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
584000 | usd |
CY2023Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
100000 | usd |
CY2024Q3 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
50000 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2465943 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1574033 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
2465943 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
1574033 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
7000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
7000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
7000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
7000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7000 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7000 | usd |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1250000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1250000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
159912808 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
159912808 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
155464808 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
155464808 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
159911 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
155463 | usd |
CY2024Q3 | LUDG |
Common Stock Issuable
CommonStockIssuable
|
40000 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
4567510 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
2618454 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-7103495 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-4242482 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2329074 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1461565 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
136869 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
112468 | usd |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
207 | usd |
us-gaap |
Revenues
Revenues
|
13254 | usd | |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
319513 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
161072 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
959160 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
845328 | usd | |
CY2024Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
172047 | usd |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
34498 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
286591 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
428708 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-491560 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-195570 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1245751 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1274036 | usd | |
CY2024Q3 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-491353 | usd |
CY2023Q3 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-195570 | usd |
us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-1232497 | usd | |
us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-1274036 | usd | |
CY2024Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
377774 | usd |
CY2023Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
186160 | usd |
us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
897774 | usd | |
us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
289017 | usd | |
us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
677130 | usd | |
CY2024Q3 | us-gaap |
Interest Expense
InterestExpense
|
16815 | usd |
CY2023Q3 | us-gaap |
Interest Expense
InterestExpense
|
4003 | usd |
us-gaap |
Interest Expense
InterestExpense
|
38612 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
9175 | usd | |
CY2023Q3 | LUDG |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
61733 | usd |
LUDG |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
15000 | usd | |
LUDG |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
434514 | usd | |
CY2024Q3 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-394589 | usd |
CY2023Q3 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-251896 | usd |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-1628516 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-732706 | usd | |
CY2024Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-885942 | usd |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-447466 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2861013 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2006742 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-885942 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-447466 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2861013 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2006742 | usd | |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
315188929 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
315188929 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
157940477 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
157940477 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
288008800 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
288008800 | shares | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1461565 | usd |
CY2024Q1 | LUDG |
Stock Issued During Period Value Issued Common Stock Issuable For Services
StockIssuedDuringPeriodValueIssuedCommonStockIssuableForServices
|
227750 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
520000 | usd |
CY2024Q1 | LUDG |
Warrant Issued For Commitment Fee
WarrantIssuedForCommitmentFee
|
677130 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1610880 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1647565 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-364191 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2011756 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
50050 | usd |
CY2024Q3 | LUDG |
Common Stock Issued For Research And Development Expenses
CommonStockIssuedForResearchAndDevelopmentExpenses
|
100800 | usd |
CY2024Q3 | LUDG |
Stock Issued During Period Value Issued Common Stock Issuable For Services
StockIssuedDuringPeriodValueIssuedCommonStockIssuableForServices
|
40000 | usd |
CY2024Q3 | LUDG |
Warrant Issued For Inducement Expense
WarrantIssuedForInducementExpense
|
377774 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-885942 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2329074 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-826167 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
370000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
176400 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-975829 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1255596 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
45983 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
795715 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-583447 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-997345 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
36330 | usd |
CY2023Q3 | us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
186160 | usd |
CY2023Q3 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
122873 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-447466 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1345194 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2861013 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2006742 | usd | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
277800 | usd | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
258713 | usd | |
us-gaap |
Noncash Merger Related Costs
NoncashMergerRelatedCosts
|
100800 | usd | |
us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
40000 | usd | |
LUDG |
Stock Warrants Issued For Finance Expense
StockWarrantsIssuedForFinanceExpense
|
677130 | usd | |
LUDG |
Other Noncash Income Expenses
OtherNoncashIncomeExpenses
|
-370000 | usd | |
LUDG |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
15000 | usd | |
LUDG |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
434514 | usd | |
us-gaap |
Deferred Sales Inducements Amortization Expense
DeferredSalesInducementsAmortizationExpense
|
897774 | usd | |
us-gaap |
Deferred Sales Inducements Amortization Expense
DeferredSalesInducementsAmortizationExpense
|
289017 | usd | |
LUDG |
Provision For Obsolete Inventory
ProvisionForObsoleteInventory
|
46981 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
46981 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
29384 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
4133 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
357910 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
79066 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-523983 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-579565 | usd | |
us-gaap |
Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
|
-60000 | usd | |
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
524000 | usd | |
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
70000 | usd | |
us-gaap |
Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
|
-55000 | usd | |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
50000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
459000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
70000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-64983 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-509565 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
108335 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
516195 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
43352 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6630 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
5000 | usd | |
us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
15000 | usd | |
us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
30000 | usd | |
us-gaap |
Notes Issued1
NotesIssued1
|
692858 | usd | |
us-gaap |
Stock Issued1
StockIssued1
|
122873 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
2861013 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-523983 | usd | |
CY2024Q3 | us-gaap |
Retained Earnings Appropriated
RetainedEarningsAppropriated
|
7103495 | usd |
CY2024Q3 | LUDG |
Stockholders Deficit
StockholdersDeficit
|
2329074 | usd |
CY2024Q3 | LUDG |
Working Capital Deficit
WorkingCapitalDeficit
|
2329074 | usd |
CY2024Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
43352 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_z4D5AVaseWvf" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zd49pNtP6kk5">Use of Estimates</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates during the nine months ended September 30, 2024 and 2023 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
us-gaap |
Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure
RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure
|
<p id="xdx_847_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_z4q0vHsCvwR1" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zm8uJkphYMJa">Revenue recognition</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied. </span></td></tr></table> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
286591 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
428708 | usd | |
us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
174303 | usd | |
us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
121397 | usd | |
CY2024Q3 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
60000 | usd |
us-gaap |
Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
|
<p id="xdx_847_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zVLKLJHgDlMg" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zC05yS8FBk11">Warrants</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | ||
us-gaap |
Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
|
700000000 | usd | |
CY2023 | us-gaap |
Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
|
700000000 | usd |
LUDG |
Stock Issued During Period Value Conversion Of Convertible Securities2
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities2
|
4840000 | usd | |
LUDG |
Stock Issued During Period Value Conversion Of Common Stock Issuable
StockIssuedDuringPeriodValueConversionOfCommonStockIssuable
|
100000 | usd | |
CY2023 | LUDG |
Stock Issued During Period Value Conversion Of Common Stock Issuable
StockIssuedDuringPeriodValueConversionOfCommonStockIssuable
|
1040000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
5145943 | shares | |
us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zMStHlrjm68f" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zd8nxU6ertbd">New Accounting Standard Adopted</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2022, the FASB issued ASU 2022-03, ASC Subtopic “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. These amendments clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments in this update are effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0">This guidance was adopted on January 1, 2024. The adoption of ASU 2022-03 did not have a material impact on the Company's consolidated financial statements.</p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2024Q3 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
1270009 | usd |
CY2023Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
1270009 | usd |
CY2023Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
100000 | usd |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
534000 | usd | |
LUDG |
Guaranteed Interest Recorded To Convertible Note Payable
GuaranteedInterestRecordedToConvertibleNotePayable
|
5000 | usd | |
LUDG |
Debt Discount Beneficial Conversion Feature Note
DebtDiscountBeneficialConversionFeatureNote
|
-10000 | usd | |
LUDG |
Guaranteed Interest Debt Dscount
GuaranteedInterestDebtDscount
|
-5000 | usd | |
us-gaap |
Repayments Of Other Debt
RepaymentsOfOtherDebt
|
55000 | usd | |
LUDG |
Accretion Of Debt Discount Recorded To Interest Expense
AccretionOfDebtDiscountRecordedToInterestExpense
|
15000 | usd | |
CY2024Q3 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
584000 | usd |
CY2024Q3 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
584000 | usd |
CY2023Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
100000 | usd |
CY2024Q3 | LUDG |
Convertible Notes Payable Net
ConvertibleNotesPayableNet
|
584000 | usd |
CY2023Q4 | LUDG |
Convertible Notes Payable Net
ConvertibleNotesPayableNet
|
100000 | usd |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
2541276 | shares |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.30 | |
CY2024Q3 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
377774 | usd |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
38612 | usd | |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
9175 | usd | |
LUDG |
Monthly Payment Second
MonthlyPaymentSecond
|
5000 | usd | |
LUDG |
Monthly Payment Second
MonthlyPaymentSecond
|
5000 | usd | |
LUDG |
Monthly Payment Second
MonthlyPaymentSecond
|
5000 | usd | |
CY2024Q3 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
750000 | shares |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
100800 | usd |
CY2024Q3 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
245712 | usd |
CY2024Q3 | LUDG |
Royalty Percentage
RoyaltyPercentage
|
0.05 | pure |
CY2024Q3 | LUDG |
Royalty Payable Percentage
RoyaltyPayablePercentage
|
0.025 | pure |
CY2024Q3 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
750000 | shares |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
100800 | usd |
CY2024Q3 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
245712 | usd |
CY2024Q3 | LUDG |
Royalty Percentage
RoyaltyPercentage
|
0.05 | pure |
CY2024Q3 | LUDG |
Royalty Payable Percentage
RoyaltyPayablePercentage
|
0.025 | pure |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1250000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
1 | ||
CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
7000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
7000000 | shares |
us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
143000 | shares | |
us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
50050 | usd | |
us-gaap |
Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
|
750000 | shares | |
CY2024Q3 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
0.13 | |
us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
100800 | usd | |
CY2024Q3 | us-gaap |
Shares Issued
SharesIssued
|
100000 | shares |
CY2024Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
40000 | shares |
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
2604667 | shares |
CY2024Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
677130 | usd |
CY2024Q1 | LUDG |
Exercise Price Per Warrant Value
ExercisePricePerWarrantValue
|
30000000 | usd |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
2541276 | shares |
CY2024Q3 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
377774 | usd |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.30 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
5145943 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.25 | ||
LUDG |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3
|
P3Y6M7D | ||
CY2024Q3 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
5145943 | usd |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.25 | |
LUDG |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y1M6D | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5145943 | shares |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.25 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y1M6D | ||
CY2024Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
0 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
2.41 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
3.38 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0413 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0443 | pure |